Clinical Utility of Circulating Tumor DNA in Advanced Rare Cancers

Clinical Utility of Circulating Tumor DNA in Advanced Rare Cancers

PurposePatients with advanced/relapsed rare cancers have few treatment options. Analysis of circulating tumor DNA in plasma may identify actionable genomic biomarkers using a non-invasive approach.Patients and MethodsRare cancer patients underwent prospective plasma-based NGS testing. Tissue NGS to...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hitomi Sumiyoshi Okuma, Kan Yonemori, Yuki Kojima, Maki Tanioka, Kazuki Sudo, Emi Noguchi, Susumu Hijioka, Keiko Wakakuwa, Ken Kato, Akihiro Hirakawa, Aya Kuchiba, Takashi Kubo, Hitoshi Ichikawa, Akihiko Yoshida, Yasushi Yatabe, Kenichi Nakamura, Hiroyuki Mano, Noboru Yamamoto, Yasuhiro Fujiwara
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
rare cancer
CtDNA (circulating tumor DNA)
precision medicine
soft tissue sarcoma
targeted therapy
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Acceso en línea:https://doaj.org/article/35ecf0472ced44858aa96591a8e7fa2a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/35ecf0472ced44858aa96591a8e7fa2a

Ejemplares similares